Immediate Impact

1 by Nobel laureates 64 standout
Sub-graph 1 of 23

Citing Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
2 intermediate papers

Works of R. Dent being referenced

KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
2019
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
2014

Author Peers

Author Last Decade Papers Cites
R. Dent 249 70 151 90 12 331
Mitsugu Yamamoto 247 88 144 32 12 330
Gabriella Landi 198 53 115 72 9 282
Göknur Giner 178 35 95 64 12 308
Manana Elia 215 103 141 84 16 329
Anthony Ferrari 147 68 149 55 15 365
Anca Mera 177 47 166 36 16 318
Vanessa de Luque 143 50 160 33 17 309
Jiguang Han 96 68 210 43 15 365
Francesca Sarno 228 40 109 28 9 327
Ina Menzl 157 65 54 96 8 341

All Works

Loading papers...

Rankless by CCL
2026